Takeda Pharmaceutical (TAK) AI Analysis
TAK$21.41—
Market cap$69.55BEnterprise value—Revenue (TTM)—Market positionTop 25%
Score
53
Neutral
Value
53
Quality
47
Growth
60
Takeda Pharmaceutical is a mixed profile at 53/100 — Value 53, Growth 60, Quality 47. Under the hood: P/E 28.5, about 20% below its own multi-year median, plus revenue compounding ~4% annually over recent years.